Latest Breaking News On - Optimal global pivotal phase - Page 1 : comparemela.com

PRIME Designation Granted Based on Phase 2 ARCHER Trial Results, which Showed Meaningful Preservation of Visual Function in Patients with Geographic Atrophy ANX007 is the First Therapeutic.

San franciscoUnited statesSheryl seapyChelcie listerAnnexon incAmerican academy of ophthalmologyEuropean medicines agencyAmerican society of retina specialistsSecurities exchangeCompany engagingStrategic communicationsGranted basedShowed meaningful preservationVisual functionFirst therapeutic candidateOptimal global pivotal phase